Skip to main content

Table 1 Demographic features of participants included in the current study

From: Small vessel cerebrovascular disease is associated with cognition in prospective Alzheimer’s clinical trial participants

 

A4

(elevated amyloid)

LEARN

(non-elevated amyloid)

Total

Test statistic

n

1250

541

1791

––

Sex/gender

 Women, n (%)

735 (58.5%)

331 (61.2%)

1066 (59.5%)

χ2 = 0.79

p = 0.37

Age

 Mean (SD), years

72.0 (4.85)

70.5 (4.30)

71.6 (4.74)

t = 6.63

p < 0.001

Ethnicity

 Hispanic or Latinx, n (%)

36 (2.9%)

18 (3.3%)

54 (3.0%)

χ2 = 0.45

p = 0.79

 Not Hispanic or Latinx, n (%)

1202 (96.2%)

519 (95.9%)

1721 (96.1%)

 Unknown, n (%)

12 (1.0%)

4 (0.7%)

16 (0.9%)

Race

 American Indian or Alaskan Native, n (%)

2 (0.2%)

5 (0.9%)

7 (0.4%)

χ2 = 5.75

p = 0.21

 Asian, n (%)

27 (2.2%)

12 (2.2%)

39 (2.2%)

 Black or African American, n (%)

32 (2.6%)

14 (2.6%)

46 (2.6%)

 White, n (%)

1173 (93.8%)

504 (93.2%)

1677 (93.6%)

 Unknown, n (%)

16 (1.3%)

6 (1.1%)

22 (1.2%)

Education

 Mean (SD), years

16.6 (2.81)

16.8 (2.63)

16.6 (2.76

t = 1.64

p = 0.10

WMH volume

 Total, mean (SD), cm3

12.27 (9.47)

11.91 (9.05)

12.16 (9.35)

t = 0.78

p = 0.43

 Frontal lobe, mean (SD), cm3

4.76 (4.92)

4.47 (4.52)

4.67 (4.81)

t = 1.23

p = 0.21

 Temporal lobe, mean (SD), cm3

1.25 (1.17)

1.38 (1.21)

1.29 (1.18)

t = 2.00

p = 0.04

 Parietal lobe, mean (SD), cm3

2.67 (3.11)

2.53 (2.91)

2.63 (3.05)

t = 0.93

p = 0.35

 Occipital lobe, mean (SD), cm3

2.29 (1.48)

2.14 (1.48)

2.25 (1.48)

t = 2.01

p = 0.04